CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 24 enrolled
Drug / intervention
Lasolvan tablet +17 moredrug
Likely dose
Lasolvan tablet 30 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02036775
NCT02036775Phase 1Completed

An Open-label, Randomised, Multiple-dose, Three-period Crossover Study in Healthy Male and Female Volunteers to Characterise Pharmacokinetics and Assess the Relative Bioavailability of Two New Oral Formulations of Ambroxol Hydrochloride as Lasolvan® Prolonged-release Hard Capsules 75 mg and Lasolvan® Effervescent Tablets 60 mg Compared to Lasolvan® Tablets 30 mg.

Boehringer Ingelheim·interventional·Posted Jan 15, 2014·Updated May 13, 2015

In Brief

A Phase 1 clinical trial evaluating Lasolvan tablet, Lasolvan effervescent tablet, and 2 other interventions for Healthy. Completed, enrolled 24 participants across 1 site.

Detailed Summary

To characterise pharmacokinetics and assess the relative bioavailability of two new oral formulations of ambroxol hydrochloride as Lasolvan® prolonged-release hard capsules 75 mg and Lasolvan® effervescent tablets 60 mg compared to Lasolvan® tablets 30 mg

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesRussia
Collaborators--

Timeline

Phase 1CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJan 15, 2014
Enrollment StartMar 1, 2014
Primary CompletionMay 1, 2014
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 12.5 years ago

Interventions

Lasolvan tabletdrug

One Lasolvan tablet 30 mg twice daily for 5 days.

Lasolvan tabletdrug

One Lasolvan tablet 30 mg twice daily for 5 days.

Lasolvan tabletdrug

One Lasolvan tablet 30 mg twice daily for 5 days.

Lasolvan tabletdrug

One Lasolvan tablet 30 mg twice daily for 5 days.

Lasolvan effervescent tabletdrug

One-half Lasolvan effervescent tablet 60mg twice daily for 5 days.

Lasolvan effervescent tabletdrug

One-half Lasolvan effervescent tablet 60mg twice daily for 5 days.

Lasolvan effervescent tabletdrug

One-half Lasolvan effervescent tablet 60mg twice daily for 5 days.

Lasolvan prolonged-release hard capsuledrug

One Lasolvan prolonged-release hard capsule 75 mg once daily for 5 days

Lasolvan prolonged-release hard capsuledrug

One Lasolvan prolonged-release hard capsule 75 mg once daily for 5 days

Lasolvan prolonged-released capsulesdrug

One Lasolvan prolonged-release hard capsule 75 mg once daily for 5 days

Lasolvan tabletdrug

One Lasolvan tablet 30 mg twice daily for 5 days.

Lasolvan tabletdrug

One Lasolvan tablet 30 mg twice daily for 5 days.

Lasolvan prolonged-release hard capsuledrug

One Lasolvan prolonged-release hard capsule 75 mg once daily for 5 days

Lasolvan effervescent tabletdrug

One-half Lasolvan effervescent tablet 60mg twice daily for 5 days.

Lasolvan prolonged-release hard capsuledrug

One Lasolvan prolonged-release hard capsule 75 mg once daily for 5 days

Lasolvan prolonged-release hard capsuledrug

One Lasolvan prolonged-release hard capsule 75 mg once daily for 5 days

Lasolvan effervescent tabletdrug

One-half Lasolvan effervescent tablet 60mg twice daily for 5 days.

Lasolvan effervescent tabletdrug

One-half Lasolvan effervescent tablet 60mg twice daily for 5 days.